Koury Shaheed Form 4 Quorum Health / Shaheed Koury ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Koury Shaheed

(Last) (First) (Middle)

1573 MALLORY LANE

SUITE 100

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Quorum Health Corp [ QHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
02/22/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.0001 per share	02/22/2018		F		1,236	D	$6.16	122,444	D
Common stock, par value $0.0001 per share	03/01/2018		F		99	D	$5.68	122,345	D
Common stock, par value $0.0001 per share	05/03/2018		F		2,301	D	$7.41	120,044	D
Common stock, par value $0.0001 per share	02/22/2019		F		4,125	D	$2.54	115,919	D
Common stock, par value $0.0001 per share	03/09/2019		F		1,236	D	$2.35	114,683	D
Common stock, par value $0.0001 per share	05/03/2019		F		2,355	D	$1.98	112,328	D
Common stock, par value $0.0001 per share	05/31/2019		A		90,000(1)	A	$0.00	202,328	D
Common stock, par value $0.0001 per share	05/31/2019		A		50,000(2)	A	$0.00	252,328	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On May 31, 2019, the reporting person received a grant of 90,000 shares of restricted common stock pursuant to the Quorum Health Corporation 2018 Restricted Stock Plan. 100% of the number of shares of restricted stock are subject to a vesting cliff that lapses on December 17, 2020.

2. On May 31, 2019, the reporting person received a grant of 50,000 shares of restricted common stock pursuant to the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. 50% of the award is time-vested restricted stock and vests in three annual equal installments beginning on February 14, 2020, and 50% of the award is performance-based restricted common stock and vests, if at all, over a two-year performance period based on the achievement of certain performance criteria.

Remarks:

Chief Medical Officer & President, Clinical Operations

	/s/ Ray Harold McCard, Jr., Attorney in Fact for Shaheed Koury	06/04/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.